Robert B. Catell, Director at BioRestorative Therapies, Inc. (BRTX), bought 37,500 shares at $4.00 ($150K) on 2016-03-01, disclosed to the SEC on 2016-03-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |